Drug stocks sag as Amgen rises on upgrade
Posted by admin on March 28, 2009 under News | 
2 Comments to Read
Drug stocks sag as Amgen rises on upgrade
) retracted 1.6%, or 126 points, to 7,800. Amgen shares were up 2% at $52.48 after J.P. Morgan raised its rating to overweight, citing the upcoming release of key clinical data for Amgen's oncology …
Lawrence said,
<a href="http://option.albumcore.ru/?p=2&lol= monstrosity@montpelier.demoralization” rel=”nofollow”>.…
thanks!…
Marion said,
<a href="http://com.artiststead.ru/?p=1&lol= tactical@reliefs.somerset” rel=”nofollow”>.…
tnx for info!!…
Add A Comment